|
| 36733497 | The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma. | Oncoimmunology | 2023 |
| 38003426 | Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function. | Int J Mol Sci | 2023 |
| 37603182 | Unrevealing the Role of TLRs in the Pathogenesis of Autoimmune Disease by Using Mouse Model of Diabetes. | Methods Mol Biol | 2023 |
| 37122718 | The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1. | Front Immunol | 2023 |
| 37387273 | A back-door insight into the modulation of Src kinase activity by the polyamine spermidine. | Elife | 2023 |
| 36798536 | Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice. | Int J Tryptophan Res | 2023 |
| 36678277 | <i>SLC6A4</i> DNA Methylation Levels and Serum Kynurenine/Tryptophan Ratio in Eating Disorders: A Possible Link with Psychopathological Traits? | Nutrients | 2023 |
| 35054973 | Decoding the Complex Crossroad of Tryptophan Metabolic Pathways. | Int J Mol Sci | 2022 |
| 35907317 | Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition. | J Pharm Biomed Anal | 2022 |
| 35220200 | In-depth characterization of phenolic profiling of Moraiolo extra-virgin olive oil extract and initial investigation of the inhibitory effect on Indoleamine-2,3-Dioxygenase (IDO1) enzyme. | J Pharm Biomed Anal | 2022 |
| 33360496 | The double life of serotonin metabolites: in the mood for joining neuronal and immune systems. | Curr Opin Immunol | 2021 |
| 33693650 | Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation. | Hum Mol Genet | 2021 |
| 33551802 | <i>Artocarpus tonkinensis</i> Extract Inhibits LPS-Triggered Inflammation Markers and Suppresses RANKL-Induced Osteoclastogenesis in RAW264.7. | Front Pharmacol | 2021 |
| 34394118 | Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity. | Front Immunol | 2021 |
| 33968089 | Current Challenges for IDO2 as Target in Cancer Immunotherapy. | Front Immunol | 2021 |
| 34290243 | 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. | Nat Commun | 2021 |
| 33451129 | The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions. | Int J Mol Sci | 2021 |
| 31210557 | Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine. | Hum Vaccin Immunother | 2020 |
| 32024760 | Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation. | Proc Natl Acad Sci U S A | 2020 |
| 33061415 | Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients. | Int J Tryptophan Res | 2020 |
| 33055013 | Polyamines and Kynurenines at the Intersection of Immune Modulation. | Trends Immunol | 2020 |
| 33159421 | Class IA PI3Ks regulate subcellular and functional dynamics of IDO1. | EMBO Rep | 2020 |
| 32605792 | A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function. | J Autoimmun | 2020 |
| 32994209 | Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity. | Proc Natl Acad Sci U S A | 2020 |
| 32536910 | Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool. | Front Immunol | 2020 |
| 32226425 | Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine. | Front Immunol | 2020 |
| 30448912 | Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. | Virchows Arch | 2019 |
| 31354721 | Immunoregulatory Interplay Between Arginine and Tryptophan Metabolism in Health and Disease. | Front Immunol | 2019 |
| 31481962 | Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells. | Front Immunol | 2019 |
| 31337416 | Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. | J Transl Med | 2019 |
| 30797943 | Amino acid metabolism as drug target in autoimmune diseases. | Autoimmun Rev | 2019 |
| 30793469 | IL-35Ig-expressing dendritic cells induce tolerance via Arginase 1. | J Cell Mol Med | 2019 |
| 29563329 | Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes. | JCI Insight | 2018 |
| 29945890 | Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes. | Diabetes | 2018 |
| 30236470 | Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes. | Trends Mol Med | 2018 |
| 30518925 | Induction of immunosuppressive functions and NF-κB by FLIP in monocytes. | Nat Commun | 2018 |
| 30391205 | Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1. | Biochem Pharmacol | 2018 |
| 29486616 | Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4. | Expert Opin Drug Discov | 2018 |
| 27696702 | Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. | J Cell Mol Med | 2017 |
| 28450863 | The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. | Front Immunol | 2017 |
| 28214225 | A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells. | Immunity | 2017 |
| 29130057 | Differentiation of Myeloid-derived Suppressor Cells from Murine Bone Marrow and Their Co-culture with Splenic Dendritic Cells. | Bio Protoc | 2017 |
| 28771031 | Challenges in the design of reliable immuno-oncology mouse models to inform drug development. | Future Med Chem | 2017 |
| 28554057 | The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. | Curr Opin Pharmacol | 2017 |
| 28545736 | Amino-acid sensing and degrading pathways in immune regulation. | Cytokine Growth Factor Rev | 2017 |
| 26803641 | Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE. | Methods Mol Biol | 2016 |
| 26522434 | Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells. | Neuropharmacology | 2016 |
| 25278421 | LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism. | Immunobiology | 2015 |
| 26003759 | Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. | Cytokine | 2015 |
| 25215657 | Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes. | J Cell Mol Med | 2014 |